Highlights
AMEX: SYN       Synthetic Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
2.70   +0.02 (0.75%)  2.454 - 2.798  31,800

Overview

 
Avg Volume (4 weeks):808,960
4 Weeks Range:0.10 - 4.12
4 Weeks Price Volatility (%):
64.68%
52 Weeks Range:0.10 - 4.12
52 Weeks Price Volatility (%):
64.68%
Average Price Target: 3.00
Price Target Upside/Downside: +0.30

Headlines



No recent Headlines for this stock.


Business Background

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

  Be the first to like this.
 


 

4639  2951  909  154 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EEM 42.94+0.54 
 SPY 286.34+0.67 
 HMNY 0.030.00 
 GE 12.63+0.33 
 AMD 20.40+0.42 
 BAC 31.02+0.15 
 XLF 28.37+0.11 
 F 9.86+0.14 
 WPZ 47.37-0.18 
 MU 49.94+1.87 
Partners & Brokers